Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28ff7b646f82a607e40da1dd9c5ae2f3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate |
2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ec435b9204f56f8f96853dee1b1afd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22e747247c3e1b7dbc58c9ccc6f89ce9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce6c899039eb97b5d53b1181af3b425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9611185bcf0d36d45f2860e67b2238 |
publicationDate |
2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017153415-A1 |
titleOfInvention |
Ophthalmological composition |
abstract |
The invention relates to an ophthalmological composition with high viscosity. The claimed composition contains or consists of hyaluronic acid or a hyaluronic acid derivative such as an ophthalmologically acceptable salt of the hyaluronic acid, and ectoine or an ophthalmologically acceptable ectoine derivative. The composition is also characterised in that it does not contain any other pharmaceutically active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3426226-B1 |
priorityDate |
2016-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |